Vestibular disorders, Meniere's disease

Indication for Cinnarizine

Population group: Suitable for both men and women, only children (1 year - 12 years old)

Cinnarizine is for the control of vestibular disorders such as vertigo, tinnitus, nausea and vomiting such as is seen in Meniere’s disease.

For this indication, competent medicine agencies globally authorize below treatments:

45 mg in 3 divided doses daily

Route of admnistration

Oral

Defined daily dose

45 - 45 mg

Dosage regimen

From 15 To 15 mg 3 time(s) per day every day

Detailed description

Children 5 to 12 years: 15 mg three times a day.

Dosage considerations

Cinnarizine should preferably be taken after meals.

Active ingredient

Cinnarizine has been shown to be a non-competitive antagonist of the smooth muscle contractions caused by various vasoactive agents including histamine. Cinnarizine also acts on vascular smooth muscle by selectively inhibiting the calcium influx into depolarised cells, thereby reducing the availability of free Ca2+ ions for the induction and maintenance of contraction.

Read more about Cinnarizine

Related medicines

Summary of Product Characteristics (SPC) 2018: STUGERON Tablet

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner